NIAID signs multimillion-dollar deal with ATCC

By The Science Advisory Board staff writers

November 23, 2021 -- The U.S. National Institute of Allergy and Infectious Diseases (NIAID), an agency of the National Institutes of Health, awarded a seven-year contract valued at up to $545 million to ATCC to aid NIAID's research efforts in infectious and allergic diseases.

Under the indefinite delivery/indefinite quality contract, ATCC will support NIAID's Division of Clinical Research, Division of Intramural Research, and the Vaccine Research Center by providing rapid response capabilities to infectious diseases, such as COVID-19, as well as services, like assay development and vaccine production.

ATCC is a biological materials and information resource and standards organization, as well as a developer and supplier of authenticated cell lines and microorganisms.

Copyright © 2021
To access all The ScienceBoard content create a free account now:

Email Address:  

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

Letter from the Editor Please send me twice-weekly roundups of all the latest life research and industry news.
SAB Announcements Please send me the latest announcements from The Science Advisory Board and their partners.
Spotlight Receive notifications about new content, services, or educational resources designed to help you sharpen your skills and grow professionally.
I have read and agree to the privacy policy and terms of service and wish to opt-in for

Already have an account? Sign in here